NYSE:ANVS

Annovis Bio Stock Predictions

etoro logo Buy ANVS
*Your capital is at risk
$1.85
-0.0100 (-0.538%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ANVS Prediction Chart

ANVS Predictions History

Latest community submissions for ANVS.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 26, 2025 $2.32 +3.45% $2.43 V 95.36% 1
Aug 26, 2025 $2.29 +2.15% $2.43 V 94.17% 1
Aug 26, 2025 Bullish $2.43 V 1
Jul 9, 2025 $2.46 -2.68% $2.72 X 90.53% 0
Jul 9, 2025 Bearish $2.72 X 0
Jun 30, 2025 $2.12 +3.65% $2.17 V 97.92% 1
Jun 30, 2025 Bearish $2.17 X 0
Jun 26, 2025 $2.42 +5.50% $2.17 X 88.67% 0
Jun 26, 2025 $2.37 +3.43% $2.17 X 90.85% 0
Jun 26, 2025 Bearish $2.17 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ANVS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ANNOVIS BIO, INC.
Annovis Bio
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for prote...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE